Target intelligence / Profile preview

Russell's viper venom serine protease (RVV-SP)

Target
RVV-SP
Molecular classification
Enzyme, Serine protease, S1 family peptidase, Clan SA
01

Overview

Russell's viper venom serine proteases (SVSPs) are a group of enzymatic toxins found in the venom of the Russell's viper (Daboia russelii), a snake of significant medical importance in South and Southeast Asia [1.1.1, 1.3.2]. The most prominent member of this family is the Factor V activator (RVV-V), which specifically cleaves and activates host coagulation Factor V, leading to the assembly of the prothrombinase complex and the rapid generation of thrombin [1.3.3, 1.4.1]. This procoagulant activity results in venom-induced consumptive coagulopathy (VICC), characterized by the depletion of clotting factors and a high risk of life-threatening hemorrhage or thrombosis [1.1.3, 1.4.3]. SVSPs are the primary targets of therapeutic antivenoms and are being investigated as targets for small-molecule inhibitors like nafamostat to improve treatment accessibility [1.2.1, 1.2.2]. Beyond their role in envenomation, these proteases are also employed as diagnostic reagents in the dilute Russell's Viper Venom Time (dRVVT) test to detect lupus anticoagulants in patient plasma [1.4.2].

Other names
Factor V activatorRVV-VSnake venom serine proteaseSVSPDaboia russelii serine proteaseAlpha-fibrinogenaseBeta-fibrinogenase
02

Mechanism of action

Inhibition of the serine protease catalytic triad (His57, Asp102, Ser195) to prevent the proteolytic activation of Factor V and other coagulation factors, thereby inhibiting the formation of the prothrombinase complex and preventing venom-induced consumptive coagulopathy.

03

Biological functions

Blood coagulationHemostasisProteolysisFactor V activationFibrinogenolysis
04

Disease associations

Snakebite envenomationCoagulopathyHemorrhageThrombosisAcute kidney injury
05

Safety considerations

Geographic variation in venom isoformsAntivenom-induced hypersensitivity and anaphylaxisIncomplete neutralization of low-molecular-weight toxinsPotential for delayed systemic envenomation
06

Interacting drugs

Antivenom

3 more in the full profile.

07

Biomarkers

Factor V activityFibrinogen levelsProthrombin time (PT)Activated partial thromboplastin time (aPTT)Dilute Russell's Viper Venom Time (dRVVT)

Beyond the preview

Go deeper on Russell's viper venom serine protease (RVV-SP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Russell's viper venom serine protease (RVV-SP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call